FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973488341> ?p ?o ?g. }

• W1973488341 endingPage "e2940" @default.
• W1973488341 startingPage "e2940" @default.
• W1973488341 abstract "Background Apical Membrane Antigen 1 (AMA1), a polymorphic merozoite surface protein, is a leading blood-stage malaria vaccine candidate. This is the first reported use in humans of an investigational vaccine, AMA1-C1/Alhydrogel, with the novel adjuvant CPG 7909. Methods A phase 1 trial was conducted at the University of Rochester with 75 malaria-naive volunteers to assess the safety and immunogenicity of the AMA1-C1/Alhydrogel+CPG 7909 malaria vaccine. Participants were sequentially enrolled and randomized within dose escalating cohorts to receive three vaccinations on days 0, 28 and 56 of either 20 µg of AMA1-C1/Alhydrogel®+564 µg CPG 7909 (n = 15), 80 µg of AMA1-C1/Alhydrogel® (n = 30), or 80 µg of AMA1-C1/Alhydrogel+564 µg CPG 7909 (n = 30). Results Local and systemic adverse events were significantly more likely to be of higher severity with the addition of CPG 7909. Anti-AMA1 immunoglobulin G (IgG) were detected by enzyme-linked immunosorbent assay (ELISA), and the immune sera of volunteers that received 20 µg or 80 µg of AMA1-C1/Alhydrogel+CPG 7909 had up to 14 fold significant increases in anti-AMA1 antibody concentration compared to 80 µg of AMA1-C1/Alhydrogel alone. The addition of CPG 7909 to the AMA1-C1/Alhydrogel vaccine in humans also elicited AMA1 specific immune IgG that significantly and dramatically increased the in vitro growth inhibition of homologous parasites to levels as high as 96% inhibition. Conclusion/Significance The safety profile of the AMA1-C1/Alhydrogel+CPG 7909 malaria vaccine is acceptable, given the significant increase in immunogenicity observed. Further clinical development is ongoing. Trial Registration ClinicalTrials.gov NCT00344539" @default.
• W1973488341 created "2016-06-24" @default.
• W1973488341 creator A5001550874 @default.
• W1973488341 creator A5009730605 @default.
• W1973488341 creator A5021691619 @default.
• W1973488341 creator A5023161333 @default.
• W1973488341 creator A5026520542 @default.
• W1973488341 creator A5028156362 @default.
• W1973488341 creator A5031853180 @default.
• W1973488341 creator A5038289296 @default.
• W1973488341 creator A5041853052 @default.
• W1973488341 creator A5044238027 @default.
• W1973488341 creator A5056491453 @default.
• W1973488341 creator A5056670181 @default.
• W1973488341 creator A5066321691 @default.
• W1973488341 creator A5079142033 @default.
• W1973488341 creator A5089823757 @default.
• W1973488341 date "2008-08-13" @default.
• W1973488341 modified "2023-10-14" @default.
• W1973488341 title "Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria" @default.
• W1973488341 cites W1871678940 @default.
• W1973488341 cites W1964499525 @default.
• W1973488341 cites W1970706410 @default.
• W1973488341 cites W1971455589 @default.
• W1973488341 cites W1972365393 @default.
• W1973488341 cites W1975785277 @default.
• W1973488341 cites W1986169276 @default.
• W1973488341 cites W1998557348 @default.
• W1973488341 cites W2011174000 @default.
• W1973488341 cites W2013610363 @default.
• W1973488341 cites W2016478573 @default.
• W1973488341 cites W2017239875 @default.
• W1973488341 cites W2042323803 @default.
• W1973488341 cites W2043875385 @default.
• W1973488341 cites W2055752862 @default.
• W1973488341 cites W2058014784 @default.
• W1973488341 cites W2071238927 @default.
• W1973488341 cites W2075789186 @default.
• W1973488341 cites W2084229289 @default.
• W1973488341 cites W2085835971 @default.
• W1973488341 cites W2089901811 @default.
• W1973488341 cites W2094712966 @default.
• W1973488341 cites W2114481416 @default.
• W1973488341 cites W2119234385 @default.
• W1973488341 cites W2126082637 @default.
• W1973488341 cites W2137059754 @default.
• W1973488341 cites W2146223790 @default.
• W1973488341 cites W2170277678 @default.
• W1973488341 cites W2469235726 @default.
• W1973488341 doi "https://doi.org/10.1371/journal.pone.0002940" @default.
• W1973488341 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2491586" @default.
• W1973488341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18698359" @default.
• W1973488341 hasPublicationYear "2008" @default.
• W1973488341 type Work @default.
• W1973488341 sameAs 1973488341 @default.
• W1973488341 citedByCount "104" @default.
• W1973488341 countsByYear W19734883412012 @default.
• W1973488341 countsByYear W19734883412013 @default.
• W1973488341 countsByYear W19734883412014 @default.
• W1973488341 countsByYear W19734883412015 @default.
• W1973488341 countsByYear W19734883412016 @default.
• W1973488341 countsByYear W19734883412017 @default.
• W1973488341 countsByYear W19734883412018 @default.
• W1973488341 countsByYear W19734883412019 @default.
• W1973488341 countsByYear W19734883412020 @default.
• W1973488341 countsByYear W19734883412021 @default.
• W1973488341 countsByYear W19734883412022 @default.
• W1973488341 countsByYear W19734883412023 @default.
• W1973488341 crossrefType "journal-article" @default.
• W1973488341 hasAuthorship W1973488341A5001550874 @default.
• W1973488341 hasAuthorship W1973488341A5009730605 @default.
• W1973488341 hasAuthorship W1973488341A5021691619 @default.
• W1973488341 hasAuthorship W1973488341A5023161333 @default.
• W1973488341 hasAuthorship W1973488341A5026520542 @default.
• W1973488341 hasAuthorship W1973488341A5028156362 @default.
• W1973488341 hasAuthorship W1973488341A5031853180 @default.
• W1973488341 hasAuthorship W1973488341A5038289296 @default.
• W1973488341 hasAuthorship W1973488341A5041853052 @default.
• W1973488341 hasAuthorship W1973488341A5044238027 @default.
• W1973488341 hasAuthorship W1973488341A5056491453 @default.
• W1973488341 hasAuthorship W1973488341A5056670181 @default.
• W1973488341 hasAuthorship W1973488341A5066321691 @default.
• W1973488341 hasAuthorship W1973488341A5079142033 @default.
• W1973488341 hasAuthorship W1973488341A5089823757 @default.
• W1973488341 hasBestOaLocation W19734883411 @default.
• W1973488341 hasConcept C104317684 @default.
• W1973488341 hasConcept C140173407 @default.
• W1973488341 hasConcept C150194340 @default.
• W1973488341 hasConcept C159047783 @default.
• W1973488341 hasConcept C190727270 @default.
• W1973488341 hasConcept C203014093 @default.
• W1973488341 hasConcept C2777863537 @default.
• W1973488341 hasConcept C2778048844 @default.
• W1973488341 hasConcept C2778371730 @default.
• W1973488341 hasConcept C2780868878 @default.
• W1973488341 hasConcept C54355233 @default.
• W1973488341 hasConcept C86803240 @default.
• W1973488341 hasConcept C8891405 @default.

• next